Reimann Ilona, Depner Klaus, Trapp Sascha, Beer Martin
Federal Research Center for Virus Diseases of Animals, Institute of Infectology, D-17493 Greifswald-Insel Riems, Germany.
Virology. 2004 Apr 25;322(1):143-57. doi: 10.1016/j.virol.2004.01.028.
A chimeric Pestivirus was constructed using an infectious cDNA clone of bovine viral diarrhea virus (BVDV) [J. Virol. 70 (1996) 8606]. After deletion of the envelope protein E2-encoding region, the respective sequence of classical swine fever virus (CSFV) strain Alfort 187 was inserted in-frame resulting in plasmid pA/CP7_E2alf. After transfection of in vitro-transcribed CP7_E2alf RNA, autonomous replication of chimeric RNA in bovine and porcine cell cultures was observed. Efficient growth of chimeric CP7_E2alf virus, however, could only be demonstrated on porcine cells, and in contrast to the parental BVDV strain CP7, CP7_E2alf only inefficiently infected and propagated in bovine cells. The virulence, immunogenicity, and "marker vaccine" properties of the generated chimeric CP7_E2alf virus were determined in an animal experiment using 27 pigs. After intramuscular inoculation of 1 x 10(7) TCID(50), CP7_E2alf proved to be completely avirulent, and neither viremia nor virus transmission to contact animals was observed; however, CSFV-specific neutralizing antibodies were detected from day 11 after inoculation. In addition, sera from all animals reacted positive in an E2-specific CSFV-antibody ELISA, but were negative for CSFV-E(RNS)-specific antibodies as determined with a CSFV marker ELISA. After challenge infection with highly virulent CSFV strain Eystrup, pigs immunized with CP7_E2alf were fully protected against clinical signs of CSFV infection, viremia, and shedding of challenge virus, and almost all animals scored positive in a CSFV marker ELISA. From our results, we conclude that chimeric CP7_E2alf may not only serve as a tool for a better understanding of Pestivirus attachment, entry, and assembly, but also represents an innocuous and efficacious modified live CSFV "marker vaccine".
利用牛病毒性腹泻病毒(BVDV)的感染性cDNA克隆构建了一种嵌合瘟病毒[《病毒学杂志》70(1996)8606]。在缺失包膜蛋白E2编码区后,将经典猪瘟病毒(CSFV)阿尔福特187株的相应序列读框内插入,得到质粒pA/CP7_E2alf。在转染体外转录的CP7_E2alf RNA后,观察到嵌合RNA在牛和猪细胞培养物中的自主复制。然而,嵌合CP7_E2alf病毒只能在猪细胞上高效生长,与亲本BVDV株CP7相比,CP7_E2alf在牛细胞中的感染和增殖效率较低。使用27头猪进行动物实验,测定了所产生的嵌合CP7_E2alf病毒的毒力、免疫原性和“标记疫苗”特性。肌肉注射1×10(7)半数组织培养感染剂量(TCID(50))后,CP7_E2alf被证明完全无毒,未观察到病毒血症或病毒传播给接触动物;然而,接种后第11天检测到CSFV特异性中和抗体。此外,所有动物的血清在E2特异性CSFV抗体酶联免疫吸附测定(ELISA)中呈阳性,但在用CSFV标记ELISA测定时,CSFV-E(RNS)特异性抗体呈阴性。在用高毒力CSFV株艾斯特鲁普进行攻毒感染后,用CP7_E2alf免疫的猪完全受到保护,免受CSFV感染的临床症状、病毒血症和攻毒病毒的排出,并且几乎所有动物在CSFV标记ELISA中呈阳性。根据我们的结果,我们得出结论,嵌合CP7_E2alf不仅可作为更好地理解瘟病毒附着、进入和组装的工具,而且还代表一种无害且有效的改良活CSFV“标记疫苗”。